Related Experiment Video
Updated: Jan 13, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.0K
Yttrium-90 downstages giant hepatocellular carcinoma to resectable size
Qin-Liang Fang1, Yu Xiong2, Ying-Lang Zeng3
1Department of Hepatobiliary Surgery, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China; Xiamen General Surgery Quality Control Center, Xiamen, 361000, China.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|January 11, 2026
Abstract
No abstract available in PubMed .

